GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Bliss GVS Pharma Ltd

Bliss GVS Pharma: Record date set for July 8, 2026, for FY26 final dividend

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 23 Jun 2026, 06:30 PM IST  ·  BSE ID: 289fbf3e-12c0-45ce-a0c0-359889892b3e
View Original BSE Filing (PDF)
💡
In Simple Terms
Bliss GVS Pharma announced the date shareholders must own stock to get its final dividend for FY26.
🤖 AI Summary
  • Bliss GVS Pharma set July 8, 2026, as the record date for FY26 final dividend.
  • Share transfer books close July 9-15, 2026, for dividend and AGM purposes.
  • The 41st Annual General Meeting is scheduled for July 15, 2026.
  • Final dividend is for the financial year ended March 31, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Record Date
July 08, 2026
Book Closure Start
Thursday, July 09, 2026
Book Closure End
Wednesday, July 15, 2026
AGM Date
Wednesday, July 15, 2026
🏢 How This Affects the Company
💰
Financial Impact
Confirms the intent to pay the previously recommended final dividend for FY26, impacting shareholder equity.
⚙️
Operational Impact
Requires internal processes for book closure and dividend disbursement for the financial year ended March 31, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. Owning shares by July 8, 2026, qualifies for the dividend.
👤
Who Is Affected
Shareholders on record as of July 8, 2026, are eligible for the final dividend for FY26.
🔍
Management Signal
Management is proceeding with the final dividend payout as recommended, indicating a commitment to shareholder returns.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM proceedings on July 15, 2026.
Confirmation of dividend payment date.
FY27 financial results announcement.
LOW RISK This filing is a standard procedural step for dividend distribution.
💡 Investor Takeaway
Bliss GVS Pharma confirmed July 8, 2026, as the record date for its final dividend for FY26. Share transfer books will be closed July 9-15, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Confirmed record date of July 8, 2026, for FY26 final dividend payment.
❓ Frequently Asked Questions
What is Bliss GVS Pharma's record date for the FY26 final dividend?
Bliss GVS Pharma has fixed July 08, 2026, as the record date for the payment of the final dividend for the financial year ended March 31, 2026.
When will Bliss GVS Pharma's share transfer books be closed for the dividend?
The company's register of members and share transfer books will remain closed from Thursday, July 09, 2026, to Wednesday, July 15, 2026, inclusive.
When is Bliss GVS Pharma's 41st Annual General Meeting scheduled?
The 41st Annual General Meeting of Bliss GVS Pharma is scheduled to be held on Wednesday, July 15, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.